iRhythm Technologies (IRTC) Stock: $155 Target And Buy Rating

By Amit Chowdhry ● Updated June 29, 2022
  • The shares of iRhythm Technologies Inc (NASDAQ: IRTC) have received a $155 price target from BTIG. These are the details.

The shares of iRhythm Technologies Inc (NASDAQ: IRTC) have received a $155 price target from BTIG. And BTIG analyst Marie Thibault is maintaining a “Buy” rating on the shares.

Thibault adjusted the rating as part of a broader research note on medical technology and digital health names. And Thibault noted that the pain across the sector has been indiscriminate and many companies that still have healthy fundamentals, strong operating track records, and important product pipelines are losing a large amount of their market value. 

Plus Thibault added that she prefers stocks with large cash balances, a line of sight to cash flow-breakeven, consistent quarterly outperformance, and multiples that compare well against pre-COVID levels.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.